SCHEMBL5176207

SCHEMBL5176207

NC(=O)C(N[C@@H](c1cccc(C(F)(F)F)c1)S(=O)(=O)c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.44
CNR2 P34972 1/20 0.43
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
EPHX1 P07099 1/20 0.40
SYK P43405 1/20 0.40
RHOC P08134 1/20 0.39
RHOA P61586 1/20 0.39
KAT6A Q92794 1/20 0.39
ADAMTS4 O75173 1/20 0.39
MMP13 P45452 1/20 0.39
CES2 O00748 1/20 0.39
LMNA P02545 1/20 0.39
ACP3 P15309 1/20 0.39
CCR1 P32246 1/20 0.39
CCR2 P41597 1/20 0.39
KDM1A O60341 1/20 0.39
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175072 0.89 CNR2 (0.42) PPARGCNR2USP2MAPTNPSR1
SCHEMBL5113431 0.87 MAPT (0.41) PPARGCNR2USP2MAPTNPSR1
SCHEMBL5175956 0.87 FLT1 (0.40) KAT6AACP3SLC1A3SLC1A2FLT1
SCHEMBL5177184 0.86 EPHX1 (0.39) PPARGCNR2EPHX1CCR2
SCHEMBL5113412 0.86 SCN8A (0.38) PPARGCNR2USP2MAPTNPSR1
SCHEMBL5121770 0.85 TRPM8 (0.39) USP2MAPTNPSR1FLT1FLT4
SCHEMBL5186681 0.84 S1PR3 (0.39) MAPTNPSR1LMNASLC1A3SLC1A2
SCHEMBL5176226 0.84 LMNA (0.40) MAPTNPSR1LMNAFLT1FLT4
SCHEMBL5186687 0.84 S1PR3 (0.39) MAPTNPSR1LMNASLC1A3SLC1A2
SCHEMBL5176473 0.83 MAPT (0.38) PPARGMAPTNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747195-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Pfizer Products Incorporated (US) 2007-01-31 EP claimed
WO-2005095334-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS PFIZER PRODUCTS INC. (US) 2005-10-13 WO claimed